ETFs that hold ROYALTY PHARMA PLC
39 US listed ETFs hold ROYALTY PHARMA PLC. PBE holds the most, at 4.88% of the fund.
Every fund that holds it
| Fund | Name | Share of the fund | Holdings filed |
|---|---|---|---|
| PBE | Invesco Biotechnology & Genome ETF | 4.88% | Sep 19, 2026 |
| GDOC | Goldman Sachs Future Health Care Equity ETF | 1.79% | May 31, 2026 |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 1.74% | Sep 19, 2026 |
| QQQJ | Invesco NASDAQ Next Gen 100 ETF | 1.31% | Sep 19, 2026 |
| PAPI | Parametric Equity Premium Income ETF | 0.73% | Jun 30, 2026 |
| FTHI | First Trust BuyWrite Income ETF | 0.54% | Sep 18, 2026 |
| LQAI | LG QRAFT AI-Powered U.S. Large Cap Core ETF | 0.51% | Apr 30, 2026 |
| TNXT | T. Rowe Price Innovation Leaders ETF | 0.45% | Jun 30, 2026 |
| FTQI | First Trust Nasdaq BuyWrite Income ETF | 0.41% | Sep 18, 2026 |
| PBPH | Portfolio Building Block World Pharma and Biotech Index ETF | 0.34% | Jan 31, 2026 |
| VXF | Vanguard Extended Market ETF | 0.29% | Aug 31, 2026 |
| VLUE | iShares MSCI USA Value Factor ETF | 0.26% | Sep 17, 2026 |
| MTUM | iShares MSCI USA Momentum Factor ETF | 0.20% | Sep 17, 2026 |
| USNZ | Xtrackers Net Zero Pathway Paris Aligned US Equity ETF | 0.13% | May 29, 2026 |
| VCSH | Vanguard Short-Term Corporate Bond ETF | 0.12% | Aug 31, 2026 |
| CRTC | Xtrackers US National Critical Technologies ETF | 0.11% | May 31, 2026 |
| VCLT | Vanguard Long-Term Corporate Bond ETF | 0.11% | Aug 31, 2026 |
| VYM | Vanguard High Dividend Yield ETF | 0.10% | Aug 31, 2026 |
| DGRO | iShares Core Dividend Growth ETF | 0.08% | Sep 17, 2026 |
| VCIT | Vanguard Intermediate-Term Corporate Bond ETF | 0.07% | Aug 31, 2026 |
| IWD | iShares Russell 1000 Value ETF | 0.07% | Sep 17, 2026 |
| LQD | iShares iBoxx $ Investment Grade Corporate Bond ETF | 0.07% | Sep 17, 2026 |
| LQDW | iShares Investment Grade Corporate Bond BuyWrite Strategy ETF | 0.07% | Sep 17, 2026 |
| IGSB | iShares 1-5 Year Investment Grade Corporate Bond ETF | 0.06% | Sep 17, 2026 |
| IGIB | iShares 5-10 Year Investment Grade Corporate Bond ETF | 0.05% | Sep 17, 2026 |
| ONEQ | Fidelity Nasdaq Composite Index ETF | 0.05% | May 31, 2026 |
| AVUS | Avantis U.S. Equity ETF | 0.04% | May 31, 2026 |
| SCHX | Schwab U.S. Large-Cap ETF | 0.03% | May 31, 2026 |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.03% | Sep 17, 2026 |
| IWB | iShares Russell 1000 ETF | 0.03% | Sep 17, 2026 |
| URTH | iShares MSCI World ETF | 0.03% | Sep 17, 2026 |
| SCHB | Schwab U.S. Broad Market ETF | 0.03% | Jun 30, 2026 |
| AGG | iShares Core U.S. Aggregate Bond ETF | 0.03% | Sep 17, 2026 |
| BSV | Vanguard Short-Term Bond ETF | 0.03% | Aug 31, 2026 |
| BND | Vanguard Total Bond Market ETF | 0.02% | Aug 31, 2026 |
| IUSB | iShares Core Universal USD Bond ETF | 0.02% | Sep 17, 2026 |
| VT | Vanguard Total World Stock Index ETF | 0.02% | Aug 31, 2026 |
| ACWI | iShares MSCI ACWI ETF | 0.02% | Sep 17, 2026 |
| SPUT | Innovator Equity Premium Income - Daily PutWrite ETF | 0.02% | Apr 30, 2026 |
What this counts
ROYALTY PHARMA PLC (ticker RPRX) is matched across every holdings book ETFIQ publishes, by its ticker together with its name. A share of the fund is the weight the issuer itself published, as of the date in the last column. Option contracts, swaps, futures, cash and money market holdings are not counted as holding a company: a fund holding a call option on a share does not hold the share. Funds whose published book is gross exposure rather than a portfolio are left out entirely, because a weight in such a book is not a share of anything.
Holdings change. Each row carries the date the fund last filed, and a fund that files quarterly can have traded since.
Cite this page. ETFIQ, ETFs holding ROYALTY PHARMA PLC, data as of Sep 21, 2026. https://etfiq.com/holdings/rprx/ Free to use with attribution; the underlying files are at Open data.